Srini Akkaraju
Managing General Partner at Samsara BioCapital
📍 Burlingame, California, United States
Srini Akkaraju is the Founder and Managing General Partner of Samsara BioCapital, a biotech investment firm focused on translating cutting-edge biology into new therapies. His career includes leadership roles at Sofinnova Ventures, New Leaf Venture Partners, and Genentech. He holds an MD and a PhD in Immunology from Stanford University.
He has a unique educational foundation, holding dual undergraduate degrees in Biochemistry and Computer Science from Rice University.
Read the full overview →Experience
24 Years
Current Role
Managing General Partner
Job Level
Senior
Location
Burlingame, California, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Srini cares about
Biotech Innovation
He believes the industry is in an "unbelievable innovation cycle" and is focused on funding transformative therapies for unmet medical needs, particularly in epigenetics and mitochondrial biology.
Drug Development
His investment philosophy centers on guiding companies through the entire risk cycle, from private funding to public markets, with a focus on building new therapeutics.
Career
Work history
Managing General Partner
Samsara BioCapital
4-2013
General Partner
Sofinnova Ventures
1-2009 - 4-2013
Managing Director
New Leaf Venture Partners
4-2006 - 12-2008
Managing Director
Panorama Capital
4-2001
Associate, Principal, Partner
JPMP
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
1990 - 1998
MD
Stanford University
1990 - 1998
MD
Stanford University School of Medicine
Social presence
Other Samsara BioCapital Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.